Pascal and Francis Bibliographic Databases



Selection :

Permanent link

Randomized open-label trial of two simplified, class-sparing regimens following a first suppressive three or four-drug regimen

FISCHL, Margaret A1 ; COLLIER, Ann C2 ; BASSETT, Roland3 ; MUKHERJEE, A. Lisa3 ; FEINBERG, Judith E4 ; DEMETER, Lisa M5 ; TEBAS, Pablo6 ; GIULIANO, Marina7 ; DEHLINGER, Marjorie8 ; GARREN, Kevin9 ; BRIZ, Barbara10
[1] Department of Medicine, University of Miami School of Medicine, Florida, United States
[2] Division of Infectious Diseases, University of Washington School of Medicine, Seattle, Washington, United States
[3] Center for Biostatistics in AIDS Research, Harvard School of Public Heath, Boston, Massachusetts, United States
[4] Division of Infectious Diseases, University of Cincinnati College of Medicine, Cincinnati, Ohio, United States
[5] Division of Infectious Diseases, University of Rochester School of Medicine and Dentistry, Rochester, New York, United States
[6] Division of Infectious Diseases, University of Pennsylvania, Philadelphia, Pennsylvania, United States
[7] Istituto Superiore di Sanitá, Rome, Italy
[8] Division of AIDS, National Institute of Allergy and Infectious Diseases, Bethesda, Maryland, United States
[9] Abbott Laboratories, Abbott Park, Illinois, United States
[10] Social and Scientific Systems, Inc, Silver Spring, Maryland, United States
Adult AIDS Clinical Trials Group A5116 Study Team

AIDS (London). 2007, Vol 21, Num 3, pp 325-333, 9 p ; ref : 32 ref

Scientific domain
Immunology, immunopathology, allergology; Microbiology, infectious diseases
Lippincott Williams & Wilkins, Hagerstown, MD
Publication country
United States
Document type
Author keyword
advanced HIV non-nucleoside reverse transcriptase inhibitor protease inhibitor simplification therapy
Keyword (fr)
Antirétroviral Antiviral Composé non nucléoside Inhibiteur protease Inhibiteur reverse transcriptase Lopinavir Ritonavir SIDA Traitement Enzyme Hydrolases Immunodéficit Immunopathologie Infection Inhibiteur enzyme Peptidases Virose
Keyword (en)
Antiretroviral agent Antiviral Non nucleoside compound Protease inhibitor Reverse transcriptase inhibitor Lopinavir Ritonavir AIDS Treatment Enzyme Hydrolases Immune deficiency Immunopathology Infection Enzyme inhibitor Peptidases Viral disease
Keyword (es)
Antiretroviral Antiviral Compuesto no nucleósido Inhibidor proteasa Inhibitor reverse transcriptase Lopinavir Ritonavir SIDA Tratamiento Enzima Hydrolases Inmunodeficiencia Inmunopatología Infección Inhibidor enzima Peptidases Virosis
002 Biological and medical sciences / 002B Medical sciences / 002B02 Pharmacology. Drug treatments / 002B02S Antibiotics. Antiinfectious agents. Antiparasitic agents / 002B02S05 Antiviral agents

002 Biological and medical sciences / 002B Medical sciences / 002B05 Infectious diseases / 002B05C Viral diseases / 002B05C02 Human viral diseases / 002B05C02D Viral diseases of the lymphoid tissue and the blood. Aids

002 Biological and medical sciences / 002B Medical sciences / 002B06 Immunopathology / 002B06D Immunodeficiencies. Immunoglobulinopathies / 002B06D01 Immunodeficiencies

Immunopathology Infectious pathology Pharmacological treatments
INIST identifier

Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS

Access to the document

Searching the Web